We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

124 hedge funds and large institutions have $1.32B invested in Ironwood Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 46 increasing their positions, 39 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more call options, than puts

Call options by funds: $6.05M | Put options by funds: $3.37M

18% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 39

15% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 13

1% more capital invested

Capital invested by funds: $1.32B → $1.32B (+$7.57M)

0% more funds holding

Funds holding: 124 → 124 (0)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

Holders
124
Holders Change
–
Holders Change %
0%
% of All Funds
3.6%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.15%
New
15
Increased
46
Reduced
39
Closed
13
Calls
$6.05M
Puts
$3.37M
Net Calls
+$2.69M
Net Calls Change
+$1.23M

Top Buyers

1
BI
BVF Inc
California
+$18M
2
Deutsche Bank
Deutsche Bank
Germany
+$14.2M
3
TI
Turner Investments
Pennsylvania
+$10.4M
4
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
+$9.25M
5
Wells Fargo
Wells Fargo
California
+$3.79M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$12.4M
2
Millennium Management
Millennium Management
New York
-$9.22M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$9.11M
4
CCP
Clough Capital Partners
Massachusetts
-$7.27M
5
CGT
Capital Guardian Trust
California
-$4.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
NCCM
101
Nine Chapters Capital Management
New Jersey
$175K -$68.6K -7,642 -30%
GCP
102
GSA Capital Partners
United Kingdom
$173K +$159K +17,748 New
Barclays
103
Barclays
United Kingdom
$132K -$309K -34,416 -71%
Two Sigma Investments
104
Two Sigma Investments
New York
$132K -$10.3K -1,152 -8%
Prudential Financial
105
Prudential Financial
New Jersey
$116K -$5.36K -597 -5%
Creative Planning
106
Creative Planning
Kansas
$100K – – –
Canada Life
107
Canada Life
Manitoba, Canada
$91K +$84K +9,363 New
CL
108
CFS LLC
Oklahoma
$87K +$80.4K +8,955 New
U
109
UBS
Switzerland
$55K +$51.2K +5,700 New
JIC
110
Joel Isaacson & Co
New York
$52K -$32.2K -3,582 -40%
Ameriprise
111
Ameriprise
Minnesota
$52K -$31.6K -3,523 -40%
Royal Bank of Canada
112
Royal Bank of Canada
Ontario, Canada
$47K -$12.5K -1,390 -23%
Teacher Retirement System of Texas
113
Teacher Retirement System of Texas
Texas
$41K -$86.9K -9,680 -70%
CA
114
CapWealth Advisors
Tennessee
$33K – – –
MCM
115
Mazama Capital Management
Oregon
$29K +$16.1K +1,789 +149%
GT
116
Glenmede Trust
Pennsylvania
$23K – – –
QT
117
Quantbot Technologies
New York
$19K +$18.2K +2,030 New
BNP Paribas Financial Markets
118
BNP Paribas Financial Markets
France
$14K -$264K -29,373 -95%
CFA
119
Carroll Financial Associates
North Carolina
$11K +$10.7K +1,194 New
EWM
120
Evercore Wealth Management
New York
$6K -$82K -9,132 -94%
PNC Financial Services Group
121
PNC Financial Services Group
Pennsylvania
$3K -$22.2K -2,468 -90%
US Bancorp
122
US Bancorp
Minnesota
$3K -$3.21K -358 -50%
TRCT
123
Tower Research Capital (TRC)
New York
$2K +$467 +52 +28%
Manulife (Manufacturers Life Insurance)
124
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$840 -$8.63K -962 -1%
TCM
125
Tygh Capital Management
Oregon
– -$2.39M -240,778 Closed
2 3 4
5
6

IRWD Hedge Fund Activity: Q4 2013 in Review

124 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q4 2013, worth a combined $1.32B — up 0.58% from $1.32B a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new IRWD positions and 13 closed out — a net gain of 2 holders — while 46 added to existing stakes and 39 trimmed.

The largest buyer was BVF Inc, adding an estimated $18M. The largest seller was Morgan Stanley, cutting an estimated $12.4M.

  • 124 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q4 2013, unchanged from Q3 2013.
  • Funds reported $1.32B of Ironwood Pharmaceuticals stock for Q4 2013, up 0.58% quarter-over-quarter.
  • 15 funds opened new Ironwood Pharmaceuticals positions in Q4 2013 and 13 closed out, a net change of +2 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q4 2013 was BVF Inc, an estimated $18M added.
  • The largest Ironwood Pharmaceuticals seller in Q4 2013 was Morgan Stanley, an estimated $12.4M sold.

Based on aggregated 13F filings for Q4 2013.